Trial Watch: Toll-like receptor agonists for cancer therapy

Toll-like receptors (TLRs) have long been known for their ability to initiate innate immune responses upon exposure to conserved microbial components such as lipopolysaccharide (LPS) and double-stranded RNA. More recently, this family of pattern recognition receptors has been attributed a critical r...

Descripción completa

Detalles Bibliográficos
Autores principales: Vacchelli, Erika, Eggermont, Alexander, Sautès-Fridman, Catherine, Galon, Jérôme, Zitvogel, Laurence, Kroemer, Guido, Galluzzi, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782517/
https://www.ncbi.nlm.nih.gov/pubmed/24083080
http://dx.doi.org/10.4161/onci.25238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782517/
https://www.ncbi.nlm.nih.gov/pubmed/24083080
http://dx.doi.org/10.4161/onci.25238

Ejemplares similares